Document is current

Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line

Crossref DOI link: https://doi.org/10.3389/fmed.2016.00076

Published Online: 2017-01-18

Update policy: https://doi.org/10.3389/crossmark-policy